How Do ECM Modulators Influence Cancer Progression?
ECM modulators can either promote or inhibit cancer progression. For instance, certain matrix metalloproteinases (MMPs) degrade the ECM, allowing cancer cells to invade surrounding tissues and metastasize. Conversely, tissue inhibitors of metalloproteinases (TIMPs) can inhibit MMP activity, potentially slowing down cancer progression.